Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 2
R&D Momentum
32/100
Pipeline Velocity
19/100
Trial Completion Rate
100/100
Pipeline Concentration
50/100
Pipeline Freshness
76/100
Strategic Signals
Activity
Last 14 days
The Effect of Tai Chi on Physical Performance in Elderly Patients With Sarcopenia: A Randomized Controlled Trial
The Effect of Golden Rice Cookies With Piper Crocatum Extract on Lipid Profile Control in Patients With Diabetes Mellitus
Intravenous Magnesium Sulfate Reduces Post-Endoscopic Symptom Severity and Attenuates IL-6 Response Following Upper Gastrointestinal Endoscopy With Biopsy: A Randomized Placebo-Controlled Trial
The Contributions of Anxiety and Self-Esteem to Imposter Syndrome Among Sports Science Undergraduates in Indonesia: A Cross-Sectional Survey
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)